Live Breaking News & Updates on Walk Acquisition|Page 1
Stay updated with breaking news from Walk acquisition. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
EFFECTOR Therapeutics (NASDAQ:EFTR – Get Rating)‘s stock had its “buy” rating reiterated by equities research analysts at JMP Securities in a research report issued to clients and investors on Monday, TipRanks reports. They presently have a $8.00 target price on the stock. JMP Securities’ price target indicates a potential upside of 64.61% from the company’s […] ....
EFFECTOR Therapeutics (NASDAQ:EFTR – Get Rating) released its quarterly earnings results on Wednesday. The company reported $0.44 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.24) by $0.68, MarketWatch Earnings reports. NASDAQ:EFTR traded up $0.07 during mid-day trading on Thursday, hitting $4.14. The company’s stock had a trading volume […] ....
De-SPACs are Falling as PIPE Shares Open Up for Sale thestreet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thestreet.com Daily Mail and Mail on Sunday newspapers.
"The Buzz" Show: Locust Walk Acquisition Corp. (NASDAQ: LWAC) Merger Approval financialbuzz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialbuzz.com Daily Mail and Mail on Sunday newspapers.
Virgin Orbit to go Public via NextGen Acquisition Corp. II thestreet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thestreet.com Daily Mail and Mail on Sunday newspapers.